Liver transplantation during infancy: No increased rate of neurological complications

Area of Science:

• Pediatric Hepatology
• Pediatric Neurology
• Transplantation Medicine

Background:

• Pediatric liver transplantation (pLT) is a vital treatment for end-stage liver and metabolic diseases in children.
• Neurological complications (NCs) are a concern post-pLT, particularly in younger, more vulnerable populations.
• Limited data exists on NCs in infants under 24 months undergoing pLT.

Purpose of the Study:

• To investigate the incidence and types of neurological complications (NCs) in children under 24 months following pediatric liver transplantation (pLT).
• To identify potential risk factors associated with NCs in this specific pediatric cohort.
• To evaluate the outcomes and prognosis of NCs in very young children post-pLT.

Main Methods:

• Retrospective study evaluating 40 children aged 19 days to 22 months who underwent pLT.
• Analysis of neurological complication types and associated clinical data.
• Statistical analysis to identify significant risk factors for NCs.

Main Results:

• Neurological complications (NCs) occurred in 20% (8/40) of patients.
• New-onset seizures were the primary NC, observed in all affected patients.
• Significant risk factors included hypothermic circulatory arrest (HAT), prolonged surgery, retransplantation, and duration of catecholamine, ventilation, and sedation therapies.
• The 3-year mortality rate was 10% (4/40 patients).

Conclusions:

• The incidence of NCs in children under 24 months post-pLT is comparable to older pediatric populations.
• New-onset seizures are the main NC, with an excellent prognosis and low risk of epilepsy in surviving infants.
• NCs did not significantly affect mortality or survival in this very young patient group.